vinyl heptanoate | 13029-86-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: vinyl heptanoate
• 英文别名: heptanoic acid vinyl ester；Heptansaeure-vinylester；Oenanthsaeure-vinylester；Vinyl-oenanthat；ethenyl heptanoate
• CAS: 13029-86-2
• 化学式: C₉H₁₆O₂
• 分子量: 156.225
• InChiKey: YSWBCVAMKPSAPW-UHFFFAOYSA-N

物化性质

• 沸点：
  182-183 °C
• 密度：
  0.8992 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  11
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  庚酸	oenanthic acid	111-14-8	C7H14O2	130.187

反应信息

• 作为反应物：
  描述：

  vinyl heptanoate 在 溴 作用下， 以 二氯甲烷 为溶剂， 以90%的产率得到1,2-dibromoethyl heptanoate
  参考文献：
  名称：

  A Novel Method for the Construction of (Z,E)- or (Z,Z)-Conjugated Alkadienyl Carboxylates

  摘要：

  [GRAPHICS]The stereocontrolled dehydrobromination of 1,2-dibromoethyl carboxylates giving (Z)-2-bromovinyl carboxylates could readily be approached by using DBU and a catalytic amount of hydroquinone as a base at -78 degreesC. The first investigation on the Suzuki-type cross-coupling of (2)-2-bromovinyl carboxylates as electrophiles with stereodefined alkenylboronic acids provides a novel method for the construction of (Z,E)or (Z,Z)-conjugated alkadienyl carboxylate moieties, which are often present in a range of natural products.

  DOI：

  10.1021/ol026286p
• 作为产物：
  描述：

  乙醛 、 庚酰氯 在 吡啶 作用下， 生成 vinyl heptanoate
  参考文献：
  名称：

  Sladkow; Petrow, Zhurnal Obshchei Khimii, 1954, vol. 24, p. 450,452;engl.Ausg.S.459,460

  摘要：

  DOI：

文献信息

• Process for the semi-continuous transvinylation of carboxylic acids with vinyl acetate
  申请人：Kotsianis Ilias S.

  公开号：US20110275852A1

  公开（公告）日：2011-11-10

  A semi-continuous process is provided for selective formation of a vinyl ester by reactive distillation from a corresponding carboxylic acid. Carboxylic acid, vinyl acetate, and a palladium acetate—bidentate ligand catalyst complex are provided and reacted in a typical embodiment. Acetic acid and vinyl acetate are continuously removed from the reaction mixture and vinyl acetate is recycled to the reaction mixture. The vinyl ester product is separated from the vinyl acetate, residual carboxylic acid, residual acetic acid, and catalyst.

  提供了一种半连续的过程，通过反应蒸馏从相应的羧酸中选择性地形成乙烯酸酯。在一个典型的实施例中，提供羧酸、乙酸乙烯酯和钯醋酸 - 双齿配体催化剂复合物并进行反应。从反应混合物中连续移除乙酸和乙酸乙烯酯，并将乙烯酸乙酯回收到反应混合物中。乙烯酸酯产品与乙烯酸乙酯、剩余羧酸、剩余乙酸和催化剂分离。
• Latex compositions containing ethylenically unsaturated esters of fatty compounds and applications thereof
  申请人：The University of Southern Mississippi

  公开号：US20010021739A1

  公开（公告）日：2001-09-13

  Novel latex or emulsion compositions containing internally plasticizing and crosslinkable monomers derived from traditional semi-drying or non-drying oils are disclosed and claimed. The monomers are ethylenically unsaturated derivatives of long-chain olefinic compounds. Preferred embodiments include latex formed from acrylate or methacrylate esters of fatty alcohols. A process for the synthesis of the latex composition is also disclosed, which involves (a) polymerization of the ethylenically unsaturated derivatives of a long-chain olefinic compound in an aqueous phase with at least one other copolymerizable monomer; and (b) blending of so formed polymer with at least one drier and a surfactant to form the novel latex or emulsion compositions. These compositions form films at low minimum film forming temperatures (MFT) ranging from −5 to 10° C. and cure to above ambient glass transition (T g ) polymers without the use of traditional organic cosolvents which contribute to environmental pollution via volatile organic compounds (VOCs) emissions. These compositions are therefore useful in waterborne coatings, contact and pressure sensitive adhesives, and inks.

  本发明揭示和声明了一种含有内部可塑化和可交联单体的新型乳胶或乳液组合物，这些单体来源于传统的半干或非干油。这些单体是长链烯烃化合物的乙烯基不饱和衍生物。首选实施例包括由脂肪醇的丙烯酸酯或甲基丙烯酸酯形成的乳胶。本发明还揭示了一种合成乳胶组合物的方法，其包括(a)在水相中聚合长链烯烃化合物的乙烯基不饱和衍生物与至少一种其他共聚单体;以及(b)将所形成的聚合物与至少一种干燥剂和表面活性剂混合以形成新型乳胶或乳液组合物。这些组合物在低最小成膜温度（MFT）范围内形成膜，该范围为-5至10°C，并在不使用传统有机共溶剂的情况下固化为高于环境玻璃转移（Tg）聚合物，这些有机共溶剂通过挥发性有机化合物（VOC）排放对环境造成污染。因此，这些组合物在水性涂料、接触和压敏胶以及油墨中具有实用价值。
• Cellulose ester film, cellulose ester dope, protective film of polarizing plate and polarizing plate
  申请人：Konica Corporation.

  公开号：US20020102369A1

  公开（公告）日：2002-08-01

  Disclosed is a cellulose ester film comprising a polymer prepared by polymerizing at least one ethylenically unsaturated monomer selected from vinyl esters, vinyl esters having a functional group, acrylic esters, and acrylic esters having a functional group, wherein the polymer has a weight average molecular weight of not more than 5,000.

  本发明公开了一种纤维素酯膜，其包括通过聚合至少一种乙烯基不饱和单体而制备的聚合物，所述乙烯基不饱和单体包括乙烯酸酯、具有功能基的乙烯酸酯、丙烯酸酯和具有功能基的丙烯酸酯，其中所述聚合物的重均分子量不超过5,000。
• Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these
  申请人：Nishi Takahide

  公开号：US20050043386A1

  公开（公告）日：2005-02-24

  Amino alcohol compounds and phosphonic acid compounds having excellent immunosuppressive activity, pharmacologically acceptable salts thereof and pharmacologically acceptable esters thereof, and pharmaceutical compositions comprising such compounds, the compounds having the following formula: wherein R 1 and R 2 each represent hydrogen, or a protecting group of the amino group; R 3 represents hydrogen, or a protecting group of the hydroxyl group; R 4 represents a lower alkyl group; n is 1 to 6; X represents oxygen or nitrogen, which is unsubstituted or substituted with a lower alkyl group; Y represents ethylene; Z represents a C 1 -C 10 alkylene; R 5 represents an aryl group; and R 6 and R 7 each represents hydrogen; provided that when R 5 represents hydrogen, then Z represents a group other than a single bond or a straight chain C 1 -C 10 alkylene group.

  具有出色的免疫抑制活性的氨基醇化合物和膦酸化合物，其药理学上可接受的盐和药理学上可接受的酯，以及包含这些化合物的制药组合物，其中化合物具有以下式子：其中R1和R2各代表氢，或氨基保护基；R3代表氢，或羟基保护基；R4代表较低的烷基；n为1至6；X代表氧或氮，未取代或取代为较低的烷基；Y代表乙烯；Z代表C1-C10烷基；R5代表芳基；R6和R7各代表氢；但是当R5代表氢时，Z代表除单键或直链C1-C10烷基组以外的一种基团。
• Amino alcohol compounds
  申请人：Nishi Takahide

  公开号：US20070105933A1

  公开（公告）日：2007-05-10

  A method for the preventing a disease selected from the group consisting of rheumatoid arthritis and psoriasis in a mammal, such as a human, in need thereof, which includes administering to the mammal a pharmaceutically effective amount of a compound of formula (Ia) wherein R 1 and R 2 are each hydrogen; R 3 is hydrogen; R 4 is C 1 -C 2 alkyl; n is 2; X is=N-D, wherein D is hydrogen, C 1 -C 4 alkyl or phenyl; Y is ethylene, ethynylene, —CO—CH 2 or phenylene; Z is ethylene or trimethylene; R 5 is an unsubstituted C 3 -C 10 cycloalkyl, an unsubstituted C 6 -C 10 aryl, or a C 3 -C 10 cycloalkyl or C 6 -C 10 aryl substituted with 1 to 3 substituents selected from the group consisting of halogen, lower alkyl, halogeno lower alkyl and lower alkoxy; and R 6 and R 7 are each hydrogen.

  本发明涉及一种用于预防哺乳动物，例如人类，需要预防风湿性关节炎和银屑病等疾病的方法，包括向哺乳动物内部给予化合物（Ia）的药物有效量，其中R1和R2均为氢; R3为氢; R4为C1-C2烷基; n为2; X为=N-D，其中D为氢、C1-C4烷基或苯基; Y为乙烯基、乙炔基、-CO-CH2或苯基; Z为乙烯基或三亚甲基; R5为未取代的C3-C10环烷基、未取代的C6-C10芳基或取代有1-3个取代基的C3-C10环烷基或C6-C10芳基，所述取代基选自卤素、低碳基、卤代低碳基和低烷氧基的群体; R6和R7均为氢。